Table 4.
Cell Lines | NSAID | Dose (μM) | Aβ40 (% of vehicle) | Aβ42 (% of vehicle) |
APC5 cell line | (S) Ibuprofen | 0 | 100 | 100 |
33 | 101 ± 8 | 96 ± 17 | ||
100 | 96 ± 15 | 79 ± 21 | ||
300 | 70 ± 13 * | 62 ± 9 * | ||
Indomethacin | 0 | 100 | 100 | |
33 | 101 ± 11 | 79 ± 21 | ||
100 | 93 ± 14 | 53 ± 12 * | ||
300 | 68 ± 11 | 11 ± 4 * | ||
Sulindac Sulfide | 0 | 100 | 100 | |
11 | 103 | 88 | ||
33 | 96 ± 5 | 64 ± 2 * | ||
100 | 57 ± 2 * | 3 ± 1 * | ||
APD3 cell line | (S) Ibuprofen | 0 | 100 | 100 |
33 | 135 ± 19 | 88 | ||
100 | 119 ± 34 | 64 ± 2 * | ||
300 | 103 ± 36 | 31 ± 11 * | ||
Indomethacin | 0 | 100 | 100 | |
33 | 95 ± 22 | 52 ± 15 * | ||
100 | 92 ± 12 * | 13 ± 11 * | ||
300 | 72 ± 16 * | 0 * | ||
Sulindac Sulfide | 0 | 100 | 100 | |
11 | 111 | 76 | ||
33 | 128 ± 18 | 56 ± 4 * | ||
100 | 64 ± 10 * | 0 * |
• * p < 0.05
• Note: at 11 μM Sulindac sulfide only one experiment was run which was the repeat experiment; due to the fact that this drug showed more potency than the others at lower doses that dose was added and the 300 μM dose was omitted since it exhibited toxicity on the cells
Each dose was run in triplicate.